Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2011-2020 of 2489 for

Edit search filters
  1. Histology of Functional Density in Postmenopausal Breast

    Rochester, MN

  2. Olmsted County Healthy Skin Study

    Rochester, MN

  3. Adrenocortical Carcinoma in Children

    Rochester, MN

  4. Evaluation Of Outcomes In Metastatic Gastric And Esophageal Carcinoma In Relation To Immunotherapy

    Rochester, MN

  5. Understanding The Patient Experience In Progesterone Management For Endometrial Cancer And Complex Atypical Hyperplasia

    Rochester, MN

  6. Patient Outcomes After Hepatic Artery Infusion Pump Placement

    Rochester, MN

  7. Examination of the Pancreas in New-onset Diabetes

    Rochester, MN

  8. Manufacturing Outcomes with Patient Factors from Multiple Myeloma Patients Prescribed Ciltacabtagene Autoleucel

    Rochester, MN

  9. A Colon Bank for Early Detection of Colon Cancer

    Rochester, MN

  10. Biomarkers To Predict For And Monitor Response To PD-1/PD-L1 Inhibitors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer